Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases

Endocrine-Related Cancer

Volumn 10, Issue 4, 2003, Pages 591-600

  Fuhrer D ^a   Tannapfel, A ^a   Sabri, O ^a   Lamesch, P ^a   Paschke, R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; IODINE 131; LEVOTHYROXINE; PHENYLALANINE; THYROTROPIN RECEPTOR; TYROSINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; MUTATION; ONCOGENE RAS; SCREENING TEST; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION; THYROID NODULE; THYROIDECTOMY; TREATMENT OUTCOME; WILD TYPE;

ADENOCARCINOMA, FOLLICULAR; ELECTROPHORESIS; HISTOCYTOCHEMISTRY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, THYROTROPIN; RNA, NEOPLASM; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS;

EID: 0347717977     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0100591     Document Type: Article

References (28)

1. Bond JA, Wyllie FS, Rowson J, Radulescu A & Wynford-Thomas D 1994 In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 9 281-290.
2. Camacho P, Gordon D, Chiefari E, Yong S, DeJong S, Pitale S, Russo D & Filetti S 2000 A Phe 486 thyrotropin receptor mutation in an autonomous functioning follicular carcinoma that was causing hyperthyroidism. Thyroid 11 1009-1012.
3. Chomczynski P & Sacchi N 1987 Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorofom extraction. Analytical Biochemistry 162 156-159.
4. Führer D, Holzapfel HP, Wonerow P, Scherbaum WA & Paschke R 1997 Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. Journal of Clinical Endocrinology and Metabolism 82 885-891.
5. Gire V & Wynford-Thomas D 2000 Ras oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation. Oncogene 19 737-744.
6. Klein CA, Blankenstein TJF, Schmidt-Kittler O, Petronia M, Polzer B, Stoecklein NH & Riethmüller G 2002 Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360 683-689.
7. Kopp P, van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE & Vassart G 1995 Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin receptor gene. New England Journal of Medicine 332 150-154.
8. Krohn K & Paschke R 2001 Progress in understanding the aetiology of thyroid autonomy. Journal of Clinical Endocrinology and Metabolism 86 3336-3345.
9. Krohn K, Reske A, Ackermann F, Mueller A & Paschke R 2001 Ras mutations are rare in solitary cold and toxic thyroid nodules. Clinical Endocrinology 55 241-248.
10. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM & Fletcher JA 2000 Pax8-PPARy 1 fusion oncogene human thyroid carcinoma. Science 289 1357-1360.
11. Leclere J, Bene MC, Aubert V, Klein M, Pascal-Vigneron V, Weryha G & Faure G 1997 Clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia. Hormone Research 47 158-162.
12. Ledent C, Dumont JE, Vassart G & Parmentier M 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO Journal 11 537-542.
13. Ledent C, Denef JF, Cottecchia S, Lefkowitz R, Dumont J, Vassart G & Parmentier M 1997 Costimulation of adenylyl cyclase and phospholipase C by a mutant alpha 1B-adrenergic receptor transgene promotes malignant transformation of thyroid follicular cells. Endocrinology 138 369-378.
14. Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R & Feunteun J 1994 Oncogenic potential of guanine nucleotide stimulatory factor α subunit in thyroid glands of transgenic mice. PNAS 91 10488-10492.
15. Mircescu H, Parma J, Huot C, Deal C, Oligny LL, Vassart G & Van Vliet G 2000 Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. Journal of Paediatrics 137 585-587.
16. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J & Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365 649-651.
17. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE & Vassart G 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 82 2695-2701.
18. Paschke R & Ludgate M 1997 The thyrotropin receptor in thyroid disease. New England Journal of Medicine 337 1675-1681.
19. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G & Avvedimento VE 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Journal of Clinical Endocrinology and Metabolism 79 657-661.
20. Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S & Suarez HG 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 11 1907-1911.
21. Russo D, Arturi F, Suarez HG, Schlumberger M, Du Villard JA, Crocetti U & Filetti S 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. Journal of Clinical Endocrinology and Metabolism 81 1548-1551.
22. Russo D, Tumino S, Arturi F, Vigneri P, Grasso G, Pontecorvi A, Filetti S & Belfiore A 1997 Detection of an activating thyrotropin receptor mutation in a case of an autonomously hyperfunctioning thyroid insular carcinoma. Journal of Clinical Endocrinology and Metabolism 82 725-738.
23. Russo D, Wong MG, Cetani G, Costante G, Chiefari E, Treseler PA, Arturi F, Filetti S & Clark OH 1999 A Val677 activating mutation of the thyrotropin receptor in a Huerthle cell cancer associated with thyrotoxicosis. Thyroid 1 13-17.
24. Spambalg D, Sharifi N, Elisei R, Gross JL, Medeiros-Neto G & Fagin JA 1996 Structural studies of the thyrotropin receptor and Gsα in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. Journal of Clinical Endocrinology and Metabolism 81 898-901.
25. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D & Paschke R 2001 Detection of thyroid-stimulating hormone receptor and Gs alpha mutations in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. Journal of Molecular Medicine 78 684-691.
26. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J & Vassart G 1995 Somatic and germline mutations of the TSH receptor gene in thyroid disease. Journal of Clinical Endocrinology and Metabolism 80 2577-2585.
27. Wynford-Thomas D 1997 Origin and progression of thyroid epithelial tumours. Cellular and molecular mechanism. Hormone Research 47 145-157.
28. Zeiger MA, Saji M, Gusev Y, Westra WH, Takiyama Y, Dooley WC, Kohn LD & Levine MA 1997 Thyroid specific expression of cholera toxic A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology 138 3133-3140.